AM

Apurva Maheshbhai Patel

Active Director Director DIN 03102991
DIN 03102991 First appointment Dec 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Dec 1998
Shareholding value •••• Premium profile

About Apurva Maheshbhai Patel

Data last updated:

Apurva Maheshbhai Patel is a Director at Farmson Basic Drugs Private Limited (since 2024), Director at Farmson Pharmaceutical Gujarat Private Limited (since 2023) and Director at Viju Enterprises Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1,334 Cr; the largest is Farmson Basic Drugs Private Limited at ₹1,222 Cr (FY 2025). Earlier, Apurva Maheshbhai Patel was a Director at Himprit Pharma Chem Private Limited (1998–2010).

DIN 03102991
Primary Designation Director
Industry Pharma
First Appointment 28 Dec 1998
Oldest Company Age 52 yrs
Largest company Farmson Basic Drugs Private Limited · ₹1,222 Cr (FY 2025)
Combined revenue ₹1,334 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Farmson Basic Drugs Private Limited U24110GJ2020PTC112370
Director15 Mar 20242020₹1,222 Cr (FY 2025)Active
Director06 Jul 20231974₹112 Cr (FY 2025)Active
Viju Enterprises Private Limited U68100GJ2025PTC160250
Director12 Mar 20252025Active
Director08 Mar 20242023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Himprit Pharma Chem Private Limited U24291GJ1998PTC033882
Director28 Dec 19981998₹35.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Viju Enterprises Private Limited
Patel Vijyaben Trusteeship Private Limited
Farmson Basic Drugs Private Limited
Farmson Pharmaceutical Gujarat Private Limited
Premium access

Shareholding and investment profile for Apurva Maheshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apurva Maheshbhai Patel

Apurva Maheshbhai Patel currently holds 4 directorships: Farmson Basic Drugs Private Limited (Director, since 15 Mar 2024, revenue ₹1,222 Cr (FY 2025)); Farmson Pharmaceutical Gujarat Private Limited (Director, since 06 Jul 2023, revenue ₹112 Cr (FY 2025)); Viju Enterprises Private Limited (Director, since 12 Mar 2025); Patel Vijyaben Trusteeship Private Limited (Director, since 08 Mar 2024).

Apurva Maheshbhai Patel was first appointed on 28 Dec 1998 as Director at Himprit Pharma Chem Private Limited. The most recent appointment on record is 12 Mar 2025 at Viju Enterprises Private Limited.

The 2 current companies of Apurva Maheshbhai Patel that report revenue have a combined latest revenue of ₹1,334 Cr: Farmson Basic Drugs Private Limited ₹1,222 Cr (FY 2025); Farmson Pharmaceutical Gujarat Private Limited ₹112 Cr (FY 2025).

Apurva Maheshbhai Patel held 1 earlier board appointment: Himprit Pharma Chem Private Limited (Director, 28 Dec 1998 to 19 Jun 2010).

The current boards of Apurva Maheshbhai Patel's companies include Aksh Apurva Patel (Farmson Basic Drugs Private Limited), Archa Ajoy Joshi (Farmson Basic Drugs Private Limited), Hiren Virendrabhai Zaveri (Farmson Basic Drugs Private Limited), Komal Samir Patel (Farmson Basic Drugs Private Limited), Milin Kaimas Mehta (Farmson Basic Drugs Private Limited), Narshibhai K Patel (Farmson Basic Drugs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available